Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Interventional × Ovarian Carcinosarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gynecologic 1

Conditions

Breast Neoplasms 6108 Neoplasms 3816 Prostatic Neoplasms 2984 Colorectal Neoplasms 2474 Carcinoma, Non-Small-Cell Lung 2362 Lung Neoplasms 2133 Leukemia, Myeloid, Acute 1659 Pancreatic Neoplasms 1602 Multiple Myeloma 1543 Carcinoma, Hepatocellular 1445 Neoplasm Metastasis 1334 Stomach Neoplasms 1275 Lymphoma 1228 Head and Neck Neoplasms 1210 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1198 Brain Neoplasms 1179 Ovarian Neoplasms 1153 Melanoma 1128 Leukemia 1109 Rectal Neoplasms 1068 Recurrence 1048 Colonic Neoplasms 999 Glioblastoma 977 Uterine Cervical Neoplasms 903 Lymphoma, Non-Hodgkin 893 Esophageal Neoplasms 814 Leukemia, Lymphocytic, Chronic, B-Cell 812 Lymphoma, Follicular 774 Lymphoma, Large B-Cell, Diffuse 771 Myelodysplastic Syndromes 768

Interventions

niraparib 1 dostarlimab 1 Antineoplastic Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03651206 2025-12-19

ROCSAN

ARCAGY/ GINECO GROUP

Phase 2/3 Recruiting

GynecologicSarcoma

Ovarian Carcinosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡